A new guanylhydrazone derivative as a potential acetylcholinesterase inhibitor for Alzheimer's disease: synthesis, molecular docking, biological evaluation and kinetic studies by nuclear magnetic resonance
Keyword(s):
Molecular docking, in silico studies and NMR show that the new guanylhydrazone is a promising compound for the treatment of Alzheimer's disease.
2014 ◽
Vol 1
(4)
◽
pp. 32-71
2008 ◽
Vol 12
(5a)
◽
pp. 1477-1485
◽
2020 ◽
Vol 19
(4)
◽
pp. 1696-1705
◽
2021 ◽
Vol 21
(11)
◽
pp. 5399-5407
2016 ◽
Vol 41
(6)
◽
pp. 1475-1482
◽
2021 ◽
Vol 64
(19)
◽
pp. 14299-14310
27Al Nuclear Magnetic Resonance and Ferron Kinetic Studies of Partially Neutralized AlCl3 Solutions1
1986 ◽
Vol 34
(5)
◽
pp. 604-607
◽